EQT Fund Management S.a r.l.

Position in EVMN — Evommune, Inc.

CIK 1834239 LUXEMBOURG, N4

Position in EVMN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$70,281,679

-$43,050,583 QoQ

Shares Held

5,288,313

+7.3% QoQ

Ownership

14.6%

of shares outstanding

% of Portfolio

8.15%

of 13F equity value

Holder Rank

of 105 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EQT Fund Management S.a r.l. holds $351,848,291 across 4 Biotechnology names. EVMN ranks #3 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHVS	Pharvaris N.V.	3,424,609	$118,422,979
2	OCS	Oculis Holding AG	6,950,294	$96,400,577
3	EVMN	Evommune, Inc. This page	5,288,313	$70,281,679
4	AGMB	Agomab Therapeutics NV	5,141,992	$66,743,056

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$70,281,679	5,288,313	+7.3%	Shares	Sole	2026-08-13
2026-03-31	$113,332,262	4,929,633	0.0%	Shares	Sole	2026-05-14
2025-12-31	$84,395,316	4,929,633	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.